Richard J. Rodgers - Oct 29, 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Oct 29, 2024
Transactions value $
$0
Form type
4
Date filed
1/2/2025, 04:52 PM
Previous filing
Jun 17, 2024
Next filing
Jan 17, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +3.8K +36.29% $0.00 14.3K Oct 29, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -3.8K -50% $0.00 3.8K Oct 29, 2024 Common Stock 3.8K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.